Loading
JPXIndustrialsSpecialty Business Services
Latest quote
¥205
−¥1.00 · -0.49%
Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Latest quote
¥205
−¥1.00 · -0.49%
Regular session · JST · Market data may be delayed.
Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Day range
Current ¥205
52-week range
Current ¥205
Regular session · JST · Market data may be delayed.
Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Day range
Current ¥205
52-week range
Current ¥205
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.67B JPY | 10.44B JPY | 12.31B JPY | 12.52B JPY | 11.56B JPY |
| Cost of goods sold | 7.91B JPY | 8.43B JPY | 8.88B JPY | 8.67B JPY | 8.22B JPY |
| Gross profit | 753.13M JPY | 2.01B JPY | 3.43B JPY | 3.84B JPY | 3.34B JPY |
| Selling, general, and administrative | 2.83B JPY | 2.59B JPY | 2.71B JPY | 2.51B JPY | 2.19B JPY |
| Operating expenses | 2.83B JPY | 2.59B JPY | 2.71B JPY | 2.59B JPY | 2.25B JPY |
| Interest income | 44.95M JPY | 60.22M JPY | 52.27M JPY | 1.81M JPY | 598K JPY |
| Interest expense | 19.99M JPY | 16.87M JPY | 17.64M JPY | 12.83M JPY | 14.18M JPY |
| Depreciation and amortization | 534.23M JPY | 537M JPY | 521.51M JPY | 503.35M JPY | 458.78M JPY |
| Operating income | −2.07B JPY | −583.5M JPY | 725.72M JPY | 1.26B JPY | 1.09B JPY |
| Net income | −3.33B JPY | −539.1M JPY | 338.27M JPY | 1B JPY | 790.49M JPY |
Company facts updated Sep 7, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥16.00
2025 complete year+14.3% since 2021
2026 partial: ¥8.00
¥14.00
2,021
¥14.00
2,022
¥14.00
2,023
¥15.00
2,024
¥16.00
2,025
¥8.00
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Mar 30, 2027 | ¥8.00Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥8.00Annual | Mar 31, 2026 | Jun 9, 2026 |
Dividend | Mar 28, 2025 | ¥16.00Annual | Mar 31, 2025 | Jun 11, 2025 |
Dividend | Mar 28, 2024 | ¥15.00Annual | Mar 31, 2024 | Jun 12, 2024 |
Dividend | Mar 30, 2023 | ¥14.00Annual | Mar 31, 2023 | Jun 8, 2023 |
Dividend | Mar 30, 2022 | ¥14.00Annual | Mar 31, 2022 | Jun 9, 2022 |
Ex-dividend Mar 30, 2027
¥8.00
Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥8.00
Annual
Record Mar 31, 2026 · Payment Jun 9, 2026
Ex-dividend Mar 28, 2025
¥16.00
Annual
Record Mar 31, 2025 · Payment Jun 11, 2025
Ex-dividend Mar 28, 2024
¥15.00
Annual
Record Mar 31, 2024 · Payment Jun 12, 2024
Ex-dividend Mar 30, 2023
¥14.00
Annual
Record Mar 31, 2023 · Payment Jun 8, 2023
Ex-dividend Mar 30, 2022
¥14.00
Annual
Record Mar 31, 2022 · Payment Jun 9, 2022
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
